Subcutaneous administration of recombinant human thyrotropin as an alternative to thyroid hormone withdrawal in patients with anticoagulated thyroid cancer: Preliminary results

Thyroid

Volumn 14, Issue 6, 2004, Pages 463-464

  Taïeb, David ^a   Lussato, D ^a   Mundler, O ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; IODINE 131; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROID HORMONE; THYROTROPIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG SAFETY; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL; SIDE EFFECT; THYROID CANCER; THYROID HORMONE WITHDRAWAL; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; FEMALE; HEMATOMA; HUMANS; INJECTIONS, SUBCUTANEOUS; IODINE RADIOISOTOPES; MALE; MEDICAL RECORDS; MIDDLE AGED; RECOMBINANT PROTEINS; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; TREATMENT OUTCOME;

EID: 3042819143     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072504323150796     Document Type: Article

References (2)

1. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A 2003 A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433-1441.
2. Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS, Weintraub BD 1997 Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 25:888-896.